License Fee and Royalties Clause Samples

License Fee and Royalties. The CONSULTANT agrees that any invention, design, process, product, device, proprietary system, or proprietary process for which an approval (of any type) may be necessary, shall be detailed by CONSULTANT in the Services Authorization, and shall be secured by the CONSULTANT (or, at the CONSULTANT's direction, by the Contractor during the CONSULTANT's construction phase services as may be memorialized in a Services Authorization) before the completion of any Services Authorization.

License Fee and Royalties. Licensee agrees to pay to Licensor a royalty on Licensed Products as follows:

License Fee and Royalties. 4.1 The LICENSEE shall pay to the LICENSOR on the execution of this MoA a sum of Rs.40000/- (Rupees Forty Thousand only) as a non-refundable one-time license fee (valid for five years). In addition, basic cost of the breeder seed of wheat variety VL Gehun 967 at the price fixed by the Department of Agriculture Co-operation & Farmers’ Welfare, MoA, GoI from time-to-time for minimum quantity of 100 kg breeder seed; a Royalty of Rs. 10/Kg of Breeder seed and the taxes as applicable. Crop Variety Amount to be paid at the time of application ▇▇▇▇▇ ▇▇ Gehun 967 40000 +18% GST = 47,200/- 15000/- Royalty for each variety: (@ Rs 10/kg of breeder seed + 18% GST ) 1000 +18% GST = 1180/- Basic cost of the seed: The basic cost of the seed will be paid by the LICENSEE at the time of delivery of the breeder seed through net banking/DD *Licensing Fee: Online transactions as per bank detail given in announcement **PPV&FRA registration Fee: By Demand Draft In Favour of “Registrar, PPV&FRA, New Delhi” payable at New Delhi Royalty and basic cost of seed for each variety: At the time of delivery of the breeder seed through netbanking/DD 4.2 Every year the Licensee will have to buy the breeder seed from the Licensor at the cost of prevailing breeder seed rates and to pay royalty and taxes as above in 4.1. 4.3 The Licensee will deposit non-refundable 10% amount of the actual cost (at the prevailing rates) of the breeder seed, royalty and taxes as applicable for the quantity it books for next year. However, this amount will be adjusted as per the rates of breeder seed prevailing at the time of delivery of seed to the licensee

License Fee and Royalties. The license fee and royalties shall be paid by Party B to Party A as follows:

License Fee and Royalties. 3.01 Licensee must pay to NCSU the non-refundable, non-creditable milestone payment set forth in Appendix B (hereafter, “Performance Milestone Fee”). The Performance Milestone Fee is due and payable within 30 days of Licensee’s achievement of such milestone. 3.02 At the times and in the manner set forth in this Agreement, Licensee must pay to NCSU a non-refundable, non-creditable running royalty on Net Sales of its and/or its licensed Affiliates’ Licensed Products and Licensed Services. The running royalty is calculated as follows: (a) [*] for Licensed Products that are [*]; (b) [*] for Licensed Products that are [*]; (c) [*] for Licensed Products that are [*]; (d) [*] for all other Licensed Products, including any by-products or extractions of Licensed Products, that are [*]; (e) [*] for Licensed Services according to [*]; and (f) If any Licensed Product that is described in 3.02 (b) or (d) above [*], the [*]. 3.03 Licensee shall pay to NCSU [*] of all non-royalty income received by Licensee as a result of its license to Patent Rights granted hereunder. Non-royalty income shall include any income, revenue or other financial consideration such as sublicensing fees, option fees, milestone payments, or royalty advances (to the extent non-refundable) received by Licensee, except for income, revenue or other financial consideration that is received directly as a running royalty on actual sales of Licensed Product or Licensed Service. It is agreed that Licensee shall not receive from a sublicensee anything of value in lieu of cash payments in consideration for any sublicense under this Agreement without the prior written permission of NCSU. 3.04 Licensee’s obligation to pay minimum annual royalties begins on January 1, 2010. Non-refundable, non-creditable minimum annual royalties are payable to NCSU as specified below. If actual royalties due under 3.02 in any year are greater than the minimum royalty payment due for that year, the minimum royalty will be credited against actual royalties due in that year. Minimum annual royalties are as follows: (a) Calendar year 2010 – 2013: [*] (b) Calendar year 2014 and each calendar year thereafter in which this Agreement is in effect: [*] 3.05 Payments required under this Agreement shall be made on or before the due date or within thirty (30) days of any invoice date on invoices received from NCSU. If overdue, payments shall bear interest until payment at the rate for past-due accounts receivable set by the Secretary of t...

License Fee and Royalties. 3.1 As part of the consideration for granting the license herein, Licensee will reimburse the University for its reasonable expenditures (including attorney's fees) arising out of the patenting of the Invention pursuant to Article 10 of this Agreement. The reimbursement of patenting costs shall be non-refundable and shall not be a credit against any other amounts due hereunder. Reimbursement of patenting costs shall be due upon monthly billings from University. (▇) Beginning on the effective date of this Agreement and continuing for the life of this Agreement, Licensee will pay University a running royalty of six percent (6%) of all Net Sales of the Licensed Product(s). In the event of sales of Licensed Product(s) in any country where a patent has not issued or wherever a competitor has commenced marketing a product generically equivalent to a Licensed Product, said royalty rate shall be reduced by 50%. (b) In the event a Licensed Product is a product in which the active compound is an invention of the University and the use thereof is not an invention of the University, in whole or in part, then the royalty set forth in 3.2(a) shall be 4% rather than 6%. No royalty shall be owed for sales of any product wherein the University has no composition of matter patent protection or the active ingredient and the use thereof is not an invention of the University, in whole or in part. 3.3 Licensee agrees to make quarterly written reports to University within 30 days after the first days of each January, April, July, and October during the life of this Agreement and as of such dates, stating in each such report the number, description, and aggregate Net Selling Prices of Licensed Products sold or otherwise disposed of during the preceding three calendar months and upon which royalty is payable as provided in Article 3.2 hereof. The first such report shall include all such Licensed Products so sold or otherwise disposed of prior to the date of such report. 3.4 Concurrently with the making of each such report, Licensee shall pay to the University royalties at the rate specified in this Agreement on the Licensed Products included therein. 3.5 If in any calendar year during the term of this Agreement after approval of a New Drug Application for a Licensed Product, total amounts payable under paragraph 3.2 hereof are less than $50,000.00, Licensee shall pay the University within thirty (30) days after the end of such calendar year, the difference between the amounts paya...

License Fee and Royalties. 6.1 In partial consideration for the Exclusive License granted by STANFORD to RIGEL with respect to the [ * ] cell lines included in the Materials, RIGEL agrees to pay to STANFORD the following: (a) A noncreditable, nonrefundable license issue royalty of ______________________, which amount shall be paid within thirty (30) days after the Effective Date. (b) An exclusivity fee equal to _______________________ for each of the three (3) years following the first anniversary of the Effective Date, which amounts shall be paid to STANFORD within thirty (30) days after each of the first, second and third anniversaries of the Effective Date. Such payments shall be nonrefundable but creditable against earned royalties to the extent provided in Section 6.4. (c) RIGEL shall issue to STANFORD _____________________ Stock of RIGEL, pursuant to a stock purchase agreement to be entered into between RIGEL and STANFORD within ninety (90) days after the Effective Date. (d) If RIGEL grants to a third party a sublicense to the Materials solely for research, and not commercialization purposes (a "Research Sublicense"), RIGEL shall also pay to STANFORD a milestone payment equal to __________________________ payment that [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. RIGEL receives as consideration for the grant of such Research Sublicense. RIGEL shall pay such amount to STANFORD within sixty (60) days after RIGEL receives such research milestone payment. If RIGEL grants to a third party a sublicense under the Materials which includes the right to sell and offer for sale Licensed Products (a "Commercialization Sublicense"), RIGEL shall pay to STANFORD a sublicense fee as follows: First Commercialization Sublicense Granted __________ Second Commercialization Sublicense Granted ____________ Each Additional Commercialization Sublicense __________ Granted If RIGEL owes amounts to STANFORD pursuant to this Section 6.1(d) and also pursuant to Section 6.3 of the 1996 License Agreement with respect to a particular Research Sublicense or Commercialization Sublicense, the amounts due to STANFORD pursuant to this Section 6.1(d) shall be reduced by any amounts due to STANFORD pursuant to Section 6.3 of the 1996 License Agreement with respect to such Research Sublicense or Commercialization Sublicense. RIGEL...

License Fee and Royalties. In consideration of the license granted under Section *, Samsung shall pay Lexar the amounts set forth below: (a) During the first through eighth quarters following the Effective Date, Samsung shall pay Lexar a non-refundable, non-creditable against royalties license fee of * dollars ($*), net of taxes pursuant to Section 4.6 ("Taxes"). Such * dollars, discounted at a net present value of five percent (5%), shall be due and payable on or before March 29, 2002. The discounted net present value of * dollars ($*) is * dollars ($*). The first eight quarters of this Agreement shall be referred to as the "*." (b) After the *, Samsung shall pay Lexar the non-refundable royalties specified in Section 1 of Exhibit A for each * sold or distributed by Samsung or its Affiliates. Such royalties will be due and payable within sixty (60) calendar days after the end of June and December for the preceding six-month period. Notwithstanding the foregoing, no royalty will accrue on sales of * or Lexar for further resale by * on an OEM basis. The parties expressly acknowledge that the amount of such royalties is reasonable, taking into account the anticipated discontinuance by *. * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

License Fee and Royalties. (a) Guaranteed Licensing Fees and Running Royalties. Throughout the term (including Option Periods) of this Agreement the Running Royalty shall be 5% of Net Sales of Royalty Bearing Products, Nonni's shall remit such Running Royalties to MFB on the last day of the month following the end of each calendar quarter covered by the Agreement. All Running Royalties shall be non-refundable for any reason whatsoever.